Literature DB >> 2841028

Effect of cyclic AMP on human blood platelets: induction of pseudopod formation and protein phosphorylation.

D R Maurer1, M H Majercik, L Y Bourguignon.   

Abstract

A variety of techniques, including immunofluorescence, electron microscopy and biochemical analysis, were used to examine shape changes and cytoskeletal reorganization of human blood platelets during treatment with N6,O2-dibutyryl adenosine 3',5'-cyclic monophosphoric acid (dbcAMP), and agent known to elevate the intracellular level of cyclic AMP (cAMP). Cytochemical analysis shows that the unstimulated platelets have a discoid shape with no obvious membrane projections. Platelets treated with dbcAMP produce pseudopod-like structures containing cytoskeletal proteins such as actin and microtubules. Biochemical analysis reveals that a 125,000 dalton phosphoprotein (P-125) is preferentially recruited into cytoskeletal fractions of platelets treated with dbcAMP. This protein, which is one of the substrates for cAMP-dependent kinase(s) and/or is closely associated with the cytoskeleton, may play an important role in regulating the shape changes and cytoskeletal reorganization that occur during the early stages of platelet activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841028     DOI: 10.1016/0309-1651(88)90072-0

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  2 in total

1.  The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane.

Authors:  Y Yano; J Kambayashi; E Shiba; M Sakon; E Oiki; K Fukuda; T Kawasaki; T Mori
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

2.  Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.

Authors:  Y Yano; M Sakon; J Kambayashi; T Kawasaki; T Senda; K Tanaka; F Yamada; N Shibata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.